Accelerating Preclinical Insights with Boehringer Ingelheim

“As part of preclinical studies, Laura has been able to delineate a new role of an MMP13 protein through a well-characterized tool compound from Boehringer’s open innovation portal opnMe.com. Clever in vitro and in vivo studies led her to validate her hypotheses. From project inception to delivering robust biological data, her strategic acumen and scientific approach were the basis for her success in our opinion. She has come across as a very professional and pro-active researcher. Her standout presentation skills, highlighted at our opnMe webinar, further demonstrated her proficiency. Collaborating with Laura has been a pleasure, and we were delighted to have been able to provide our contributions to her success. We can confidently advocate her technical skills and scientific knowledge in the life-science sector.”

Florian Montel & Markus Koester, Boehringer Ingelheim